Trial · NCT04420533
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in OABSS at Week 12 | Baseline and Week 12 | Change from baseline in OABSS (Overactive Bladder Symptom Score) at Week 12 (lower OABSS score represent a better outcome) |
| Primary | Change from baseline in IIEF-5 at Week 12 | Baseline and Week 12 | Change from baseline in IIEF-5 (International Index of Erectile Function) at Week 12 (higher IIEF-5 score represent a better outcome) |
| Secondary | Change from baseline in OABSS at Week 4 | Baseline and Week 4 | Change from baseline in OABSS (Overactive Bladder Symptom Score) at Week 12 (lower OABSS score represent a better outcome) |
| Secondary | Change from baseline in IIEF-5 at Week 4 | Baseline and Week 4 | Change from baseline in IIEF-5 (International Index of Erectile Function) at Week 12 (higher IIEF-5 score represent a better outcome) |
| Secondary | Change from baseline in MSHQ-EjD Short Form score at Week 4 | Baseline and Week 4 | Change from baseline in MSHQ-EjD (Male Sexual Health Questionnaire -Ejaculatory Domain) Short Form score at Week 4 (higher MSHQ-EjD Short Form Q1-Q3 sum scores represent a better outcome; lowerer MSHQ-EjD Short Form Q4 score represent a better outcome) |
| Secondary | Change from baseline in MSHQ-EjD Short Form score at Week 12 | Baseline and Week 12 | Change from baseline in MSHQ-EjD (Male Sexual Health Questionnaire -Ejaculatory Domain) Short Form score at Week 12 (higher MSHQ-EjD Short Form Q1-Q3 sum scores represent a better outcome; lower MSHQ-EjD Short Form Q4 score represent a better outcome) |
| Secondary | Net change of Frequency episode, nocturia episode, urgency episode, UUI episodes in 3-day voiding diary from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of Frequency episode, nocturia episode, urgency episode, UUI episodes in 3-day voiding diary from baseline to 1 and 3 months after the treatment day (lower episode represent a better outcome) |
| Secondary | Net change of Qmax from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of maximum flow rate (Qmax) from baseline to 1 and 3 months after the treatment day (higher Qmax and voided volume represent a better outcome) |
| Secondary | Net change of voided volume from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of voided volume from baseline to 1 and 3 months after the treatment day (higher voided volume represent a better outcome) |
| Secondary | Net change of PVR volume from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of postvoid residual (PVR) volume from baseline to 1 and 3 months after the treatment day (lower PVR represent a better outcome) |
| Secondary | Net change of IPSS from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of IPSS (International prostate symptom score) from baseline to 1 and 3 months after the treatment day (lower IPSS represent a better outcome) |
| Secondary | Net change of PPBC score from baseline to 1 and 3 months after the treatment day | Baseline, Week 4 and Week 12 | Net change of PPBC score (Patient perception of bladder condition) from baseline to 1 and 3 months after the treatment day (lower PPBC represent a better outcome) |
| Secondary | Net changes of the GRA | Baseline, Week 4 and Week 12 | Global response assessment (GRA) of satisfaction by the patient (categorized into -3, -2, -1, 0, 1, 2, 3, indicating markedly worse to markedly improved) at 1 and 3 months after the treatment day. An improvement of GRA by 2 scales is considered effective. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04420533/registered